Insights

Strategic Partnerships Samsara Therapeutics has a track record of engaging collaborators and advisory board members (e.g., Professor Dame Pamela Shaw) and has secured grant support from The Michael J. Fox Foundation, signaling openness to co-development and externally funded research opportunities.

Neurodegeneration Focus The company concentrates on autophagy activation to combat age-related neurodegenerative diseases, with active interest in Parkinson’s disease and ALS/MND, suggesting opportunities to position offerings around translational research, biomarker work, and preclinical-to-clinical programs in neurodegeneration.

Funding Momentum Current funding levels (~$14M raised) combined with ongoing grants indicate a runway for continued collaboration on research tools, assay development, and platform validation that could benefit partners seeking early-stage discovery capabilities.

Clinical Pipeline Enablement Partnerships with disease-focused foundations (CMT Research Foundation) point to a willingness to collaborate on pipeline optimization and autophagy compound development, presenting a path for co-development of screening libraries, assays, and GMP-grade supply considerations.

Technology & Ops Footprint A lean team (11-50 employees) operating on common cloud and collaboration stacks (Google Cloud, Microsoft 365, Box) suggests potential for scalable, vendor-agnostic collaboration services, data management, and CRO/academic partnerships needing streamlined integration and project management support.

Similar companies to Samsara Therapeutics

Samsara Therapeutics Tech Stack

Samsara Therapeutics uses 8 technology products and services including WordPress, CookieYes, Shopify, and more. Explore Samsara Therapeutics's tech stack below.

Media & News

Samsara Therapeutics's Email Address Formats

Samsara Therapeutics uses at least 2 email formats:
Samsara Therapeutics Email FormatsExamplePercentage
First@samsaratherapeutics.comJohn@samsaratherapeutics.com
97%
Middle@samsaratherapeutics.comMichael@samsaratherapeutics.com
3%

Frequently Asked Questions

What is Samsara Therapeutics's official website and social media links?

Minus sign iconPlus sign icon
Samsara Therapeutics's official website is samsaratherapeutics.com and has social profiles on LinkedIn and Crunchbase.

How much revenue does Samsara Therapeutics generate?

Minus sign iconPlus sign icon
As of October 2026, Samsara Therapeutics's annual revenue is estimated to be $1M - $10M.

What is Samsara Therapeutics's SIC code and NAICS code?

Minus sign iconPlus sign icon
Samsara Therapeutics's SIC code is 8731 - Commercial Physical and Biological Research and NAICS code is 541714 - Research and Development in Biotechnology (except Nanobiotechnology).

How many employees does Samsara Therapeutics have currently?

Minus sign iconPlus sign icon
As of October 2026, Samsara Therapeutics has approximately 12 employees across 3 continents, including Europe, North America and Asia. Key team members include Vice President, Chemistry: W. G., Senior Scientist And R&d Project Manager: N. M. and Senior Scientist: N. K. S. Explore Samsara Therapeutics's employee directory with LeadIQ.

What industry does Samsara Therapeutics belong to?

Minus sign iconPlus sign icon
Samsara Therapeutics operates in the Biotechnology Research industry.

What technology does Samsara Therapeutics use?

Minus sign iconPlus sign icon
Samsara Therapeutics's tech stack includes WordPress, CookieYes, Shopify, Microsoft 365, Google Cloud, Really Simple Discovery, Box and GoDaddy.

What is Samsara Therapeutics's email format?

Minus sign iconPlus sign icon
Samsara Therapeutics's email format typically follows the pattern of First@samsaratherapeutics.com. Find more Samsara Therapeutics email formats with LeadIQ.

How much funding has Samsara Therapeutics raised to date?

Minus sign iconPlus sign icon
As of October 2026, Samsara Therapeutics has raised $14M in funding. The last funding round occurred on Nov 27, 2024.

When was Samsara Therapeutics founded?

Minus sign iconPlus sign icon
Samsara Therapeutics was founded in 2018.
Samsara Therapeutics logo

Samsara Therapeutics

Biotechnology ResearchEngland, United Kingdom11-50 Employees

Samsara Therapeutics is a biotechnology research company based in Oxford, England, focused on activating autophagy to address age-related neurodegenerative diseases. The company aims to slow the progression of debilitating conditions by targeting autophagy-related cellular processes. Its work is focused on applying autophagy biology to neurodegenerative diseases.

In June 2023, the company announced the appointment of Professor Dame Pamela Shaw to its scientific advisory board, bringing expertise in ALS/MND. The organization has engaged in collaborations with research foundations, including a partnership with the CMT Research Foundation to optimize pipeline autophagy compounds.

Section iconCompany Overview

SIC Code
8731 - Commercial Physical and Biological Research
NAICS Code
541714 - Research and Development in Biotechnology (except Nanobiotechnology)
Founded
2018
Employees
11-50

Section iconFunding & Financials

  • $14M

    Samsara Therapeutics has raised a total of $14M of funding over 6 rounds. Their latest funding round was raised on Nov 27, 2024 as a Convertible Note.

  • $1M - $10M

    Samsara Therapeutics's revenue is estimated to be in the range of $1M - $10M

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust
LeadIQ to help them build pipeline confidently.

© LeadIQ, Inc. All rights reserved.